In this observational study insights regarding the tolerability and influence on the quality of life of the topical treatment Ectoin Mund- and Rachenspray compared to Emser Pastillen in patients with acute Pharyngitis/ Laryngitis under real life conditions shall be gained. Patients are treated with Ectoin Mund- \& Rachenspray 1% or Emser Pastillen according to the demands of the physician and the instructions for use.
Study Type
OBSERVATIONAL
Enrollment
95
Norbert Pasch-Facharzt für HNO Heilkunde
Aachen, Germany
HNO Praxis Aachen Brand
Aachen, Germany
Taufik Shahab -Facharzt für HNO Heilkunde
Cologne, Germany
Bey - Facharzt f. HNO Heilkunde
Cologne, Germany
Change in Pharyngitis symptom score evaluated by the physician
Assessment of the symptoms of pharyngitis on a 4 point scale (none, mild, moderate strong): * swollen palatine tonsils * swollen lymph nodes in the throat * fever * cough
Time frame: Visit 1, Visit 2 (after 3 days), Visite 3 (after 7 days)
Change in patient's general condition evaluated by the physician
Physician's assessment of the general conditions on a 4 point scale (good condition, slightly reduced condition, bad condition, very bad condition)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days)
Change in Evaluation of the hoarseness
physician's assessment of the hoarseness of the patient on a 4 point scale (none, mild, moderate, strong)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days)
Change in Dysphagia
physician's assessment of dysphagia of the patient on a 4 point scale (none, mild, moderate, strong)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days)
Change in efficacy evaluation by the physician
Assessment of the efficacy on a 4 point scale (0= bad, 1=sufficient, 2=good, 3=very good)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 1 week)
Change in efficacy evaluation by the patient
Assessment of the efficacy on a 4 point scale (0\_bad, 1=sufficient, 2=good, 3=very good)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days)
Change in Evaluation of the tolerability by the physician
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
HNO-Praxis Peter Hinterkausen & Dr. med. Eva Bottler-Neufert
Cologne, Germany
HNo Praxis Dr. Uta Thieme
Duisburg, Germany
Dr. Lenzenhuber-Fachärztin für HNO Heilkunde
Jülich, Germany
Wilhelm Schütz -Facharzt für HNO Heilkunde
Jülich, Germany
Assessment of the tolerability by the physician on a 4 point scale (0= bad, 1=sufficient, 2=good, 3=very good)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days))
Change in Evaluation of the tolerability by the patient
Assessment of the tolerability by the patient on a 4 point scale (0= bad, 1=sufficient, 2=good, 3=very good)
Time frame: Visit 1, Visit 2 (after 3 days), Visit 3 (after 7 days))
Change in number and type of adverse events
incidence of adverse events and correlation with the therapy
Time frame: Visit 2 (after 3 days) Visit 3 (after 7 days)